Maurizio Fava
Psychiatrist-in-Chief at Massachusetts General Hospital and Slater Family Professor of Psychiatry at Harvard Medical School
Key Impact
He is a leading depression researcher whose clinical trials helped establish ketamine and esketamine as rapid-acting treatments for treatment-resistant depression and suicidality.
Background & Research
Maurizio Fava, MD, is a psychiatrist and depression researcher at Massachusetts General Hospital and Harvard Medical School. He founded the MGH Depression Clinical and Research Program and has led major clinical trial efforts in treatment-resistant depression, including work on rapidly acting antidepressant therapies such as ketamine. He previously trained in endocrinology and psychiatry at the University of Padova and Massachusetts General Hospital.
Collaboration Network
23 collaborators· click a node to visit their profile
Full network →